Amy Paller, MD

How to recognize and diagnose measles with Amy Paller, MD

🚨New podcast drop! 🚨

🎙️In the latest episode of Beneath the Surface, @joelgel.bsky.social talks with Amy Paller, MD, of @feinberg.northwestern.edu about how to recognize and diagnose #measles.

Check it out below 👇

www.healio.com/news/dermato...

@gohealio.bsky.social @healioid.bsky.social

Beneath the Surface: How to recognize and diagnose measles Measles, which was declared to be eliminated in 2000 in the United States, has seen a resurgence, with more than 2,000 cases documented in 2025.This is the highest number of cases since elimination wa...

With the possibility that measles is on the rise, we dermatologists need to be on the lookout for children or adults coming in with the measles morbilliform rash and a history (high fever,cold symptoms,eye redness) that is suspicious for this highly contagious disease
www.healio.com/news/dermato...

Exciting opportunity in the Peng Lab at Northwestern, focusing on stem cells, autophagy, and epithelial biology. Please share with interested candidates!

postdocs.northwestern.edu/announcement...

#jobSky #postdocSky #dermSky #eyeSky

Excited that 3 organizations supporting Epidermal Differentiation Disorders are teaming to sponsor a special pre-SID program in Chicago that will include experts and patients. Hope to see you there.

www.pachyonychia.org/2026-edd-sym...
#DermSky #MedSky #raredisease #EDDs

We’re excited to see our Ichthyosis community come together again!

📅 Saturday, January 17, 2026
📍 Lurie Children’s Hospital, Chicago

It’s a special chance to meet others living with Ichthyosis, hear updates on ongoing research, and enjoy some fun and support together.
We hope to see you there 💙

An Acid-Oxidising Solution Containing Hypochlorous Acid Reduces Staphylococcus aureus and Improves Bacterial Diversity in Epidermolysis Bullosa Wounds

#raredisease #epdermolysisbullosa #microbiome #dermsky #medsky

pubmed.ncbi.nlm.nih.gov/40803690/

New review article!
Deciding Which Patients With Atopic Dermatitis to Prioritize for Biologics and Janus Kinase Inhibitors

doi.org/10.1016/j.ja...

#dermsky #medsky

Treatment of Atopic Dermatitis Depends on Disease Severity

New Treatments in Atopic Dermatitis Update

#DermSky #MedSky
@annalsacaai.bsky.social

pubmed.ncbi.nlm.nih.gov/40562170/

Excited to share that three of our lab members are presenting their work at # #SIDSanDiego25! Come support them at their talks and poster sessions.
@siderm.bsky.social
#DermSky

Having a device that can measure TEWL remotely, continuously or as programmed by the investigator - and without perturbing a patient during sleep - is a major advance.

#wearabledevices #DermSky

A non-contact wearable device for monitoring epidermal molecular flux
www.nature.com/articles/s41...

A new classification of hereditary EDDs highlights shared disease mechanisms—unlocking targeted, pathogenesis-based treatments. From lovastatin-cholesterol to kallikrein inhibitors and gene editing, care for syndromic ichthyosis is evolving.
doi.org/10.1093/bjd/...

#raredisease #MedSky #DermSky

Long-term dupilumab treatment in young children (6mo–5y) with moderate-to-severe AD shows low infection rates. This reinforces its strong safety profile for pediatric eczema care.

#AtopicDermatitis #Dupilumab #PediatricDermatology #medsky #dermsky

Read more: eprints.whiterose.ac.uk/220380/

New study on tapinarof cream 1% in pediatric AD! Minimal systemic absorption, favorable safety, and good tolerability in children (2–17 yrs)with extensive AD. The treatment was well tolerated, even on sensitive skin and flexural areas, with only mild folliculitis reported. #atopicdermatitis #dermsky

Great to be at #AAD2025, sharing our lab’s work and connecting with colleagues in the field. Exciting discussions and a fantastic meeting!
Science drives innovation, informs policy, and improves lives—let’s continue to champion its role in society.

#StandUpForScience
@aadmember.bsky.social

So proud of our amazing faculty in skin research - consistently at the top and this year #2. Go Northwestern Dermatology!

#DermSky
#MedSky

Debra and @charitydebra.bsky.social are delighted to support a clinical trial led by @pallerlab.bsky.social @nufeinbergmed.bsky.social.

The trial explores #repurposing Dupilumab - used for eczema - to treat itch, blistering, and pain in all types of #EB.

Read more 👉 bit.ly/Dupilumabtot...

Great to see some action in addressing the curtailing of science

#MedSky #DermSky #ScienceSky #StandUpForScience2025

Excited about a device that both measures scratch based on finger movement and the sound of itch — and can optionally provide a haptic vibration when sensing scratch to stop it, even at night. 

pubmed.ncbi.nlm.nih.gov/39908036/

ISPD Webinar on Neonatal dermatology

Saturday, 15 February
8 AM Eastern Standard Time (EST)
London: 1 PM | Dubai: 5 PM | Perth: 9 PM

Register:
www.ispedderm.com/webinar-1-ne...

Biologics in congenital ichthyosis: are they effective?

doi: 10.1093/bjd/ljae420

pubmed.ncbi.nlm.nih.gov/39470394/

"Biologics may lead to improvement in only a subset of patients with congenital ichthyoses with only some of them noting a good response."

Use of advanced systemic therapy in patients with moderate-to-severe atopic dermatitis in the TARGET-DERM AD Registry

pubmed.ncbi.nlm.nih.gov/39623757/

#atopicdermatitis #dermatology

www.drugdiscoverynews.com/old-drugs-sh...

#raredisease #dermatology #ichthyosis